Main Article Content


Vitiligo is a chronic skin disorder due to melanocyte destruction in the epidermis. It is a social stigma. Therefore, it affects the patient psychologically as well. Various therapies have been evaluated in the management of vitiligo. Vamana is a helpful panchakarma to treat skin diseases, but it has still not been studied. To study the efficacy of Vamana, we randomly selected 30 patients with vitiligo and divided them into two groups of 15 patients in each group. For Group A, Vamana was administered, and oral Swayambhu Guggul was administered at 500 mg/day with cow urine and Savarnakar Lepa for local application. This treatment was given for six weeks. In Group -B, the same treatment was given without Vamana. The Vitiligo Area Severity Index (VASI) and overall assessment were used to assess the results. Group A decreased the score from 59.67 to 27.20 ± 18.28, and Group B decreased the score from 42.6 to 36.2 ± 7.58. The P value was statistically significant in Group A and nonsignificant in Group B. In the overall assessment, Group A showed statistically significant results. We concluded that Vamana with Shaman Chikitsa is more efficacious than Shaman Chikitsa alone, but more studies are required to ascertain whether vitiligo can be reversed completely by the combined treatment of Vamana and Shaman Chikitsa.



Ayurveda Panchakarma Suvarnakar Lepa Swayambhu Guggul Vamana Vitiligo

Article Details

How to Cite
Damor, G. K., Raut, K., & Kulkarni, S. (2023). A randomized clinical trial of Shaman chikitsa versus Shaman chikitsa with vamana in vitiligo (Shwitra). Environment Conservation Journal, 24(4), 241–247.


  1. Arora, A. K., & Kumaran, M. S. (2017). Pathogenesis of vitiligo: An update. Pigment International, 4(2), 65. DOI:
  2. Barad, S., Bhinde, S., Bedarkar, P., & Patgiri, B. (2021). Efficacy of Marichyadi Lepa Prepared with two different methods along with Abhayarishta in Shvitra (Vitiligo) – A Comparative Randomized Open label Clinical Study. Annals of Ayurvedic Medicine, 10(1), DOI:
  3. Bergqvist, C., & Ezzedine, K. (2020). Vitiligo: A Review. Dermatology, 236(6), 571–592. DOI:
  4. BS Mishr Shastri (2015 Bhavprakash by Bhav Mishra, Chaukhambha Prakashan, Varanasi.
  5. Dhanik, A., Sujatha, N., & Rai, N. P. (2011). Clinical evaluation of the efficacy of Shvitrahara XXXripath and lepa in vitiligo. Ayu, 32(1). DOI:
  6. Donata, S., Austin, S., & Kuttan, R. (1990). Clinical trial of certain ayurvedic medicines indicated in vitiligo. Ancient Science Life, 4, 202–206
  7. Hamzavi, I., Jain, H., McLean, D., Shapiro, J., Zeng, H., & Lui, H. (2004). Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative Tool: The Vitiligo Area Scoring Index. Archives of Dermatology, 140(6), 677–683. DOI:
  8. Narahari, S. R., Ryan, T. J., Bose, K. S., Prasanna, K. S., & Aggithaya, G. M. (2011). Integrating modern dermatology and Ayurveda in treating vitiligo and lymphedema in India. International Journal of Dermatology, 50(3), 310–334. DOI:
  9. Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017). New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology, 77(1), 1–13. DOI:
  10. Sarma, N., Chakraborty, S., Poojary, S., Shashi Kumar, B. M., Gupta, L. K., Budamakuntla, L., Kumrah, L., Das, S., Ovhal, A. G., Mandal, N. K., Mukherjee, S., Anoop, T. V., Thakur, B. K., Eswari, L., Samson, J. F., Patel, K. B., Rajagopalan, R., Gupta, S., & Kaur, T. (2020). A Nationwide, Multicentric Case–Control Study on Vitiligo (MEDEC-V) to Elicit the Magnitude and Correlates. Indian Journal of Dermatology, 65(6), 473. DOI:
  11. Vagbhata. (2019). Ashtang Hridaya (D. B. Tripathi (Ed.)). Chaukhambha.Prakashan, Varanasi.